101 related articles for article (PubMed ID: 14687996)
21. Development and validation of a predictive model for chemotherapy-associated thrombosis.
Khorana AA; Kuderer NM; Culakova E; Lyman GH; Francis CW
Blood; 2008 May; 111(10):4902-7. PubMed ID: 18216292
[TBL] [Abstract][Full Text] [Related]
22. Inherited thrombophilia: key points for genetic counseling.
Varga E
J Genet Couns; 2007 Jun; 16(3):261-77. PubMed ID: 17473965
[TBL] [Abstract][Full Text] [Related]
23. Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study.
Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Turpie AG; Wildgoose P; Yusen RD
J Thromb Thrombolysis; 2006 Aug; 22(1):31-8. PubMed ID: 16786230
[TBL] [Abstract][Full Text] [Related]
24. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study.
Alikhan R; Cohen AT; Combe S; Samama MM; Desjardins L; Eldor A; Janbon C; Leizorovicz A; Olsson CG; Turpie AG;
Arch Intern Med; 2004 May; 164(9):963-8. PubMed ID: 15136304
[TBL] [Abstract][Full Text] [Related]
26. Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients.
Russell MW; Taylor DC; Cummins G; Huse DM
Am J Manag Care; 2002 Jan; 8(1 Suppl):S3-9. PubMed ID: 11822347
[TBL] [Abstract][Full Text] [Related]
27. An electronic tool for venous thromboembolism prevention in medical and surgical patients.
Samama MM; Dahl OE; Mismetti P; Quinlan DJ; Rosencher N; Cornelis M; de Vries H; van Beusekom I; Kahan JP
Haematologica; 2006 Jan; 91(1):64-70. PubMed ID: 16434372
[TBL] [Abstract][Full Text] [Related]
28. Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool.
Samama MM; Dahl OE; Quinlan DJ; Mismetti P; Rosencher N
Haematologica; 2003 Dec; 88(12):1410-21. PubMed ID: 14687996
[TBL] [Abstract][Full Text] [Related]
29. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.
Cohen AT; Alikhan R; Arcelus JI; Bergmann JF; Haas S; Merli GJ; Spyropoulos AC; Tapson VF; Turpie AG
Thromb Haemost; 2005 Oct; 94(4):750-9. PubMed ID: 16270626
[TBL] [Abstract][Full Text] [Related]
30. Risk factors in venous thromboembolism.
Martinelli I
Thromb Haemost; 2001 Jul; 86(1):395-403. PubMed ID: 11487029
[TBL] [Abstract][Full Text] [Related]
31. Applying risk assessment models in non-surgical patients: overview of our clinical experience.
Davidson BL
Blood Coagul Fibrinolysis; 1999 Aug; 10 Suppl 2():S85-9. PubMed ID: 10493235
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for venous thromboembolism in children.
Gerotziafas GT
Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
